tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Ocular Therapeutix Inc

OCUL
Add to Watchlist
10.000USD
-0.500-4.76%
Close 09-23 16:00（ET）
2.19BMarket Cap
LossP/E TTM

Ocular Therapeutix Inc

10.000
-0.500-4.76%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

OCUL Financials

See Ocular Therapeutix Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
2.19B
Dividend TTM
0.00
P/E TTM
-6.96
EPS TTM
-1.44
Revenue
51.95M
Net Profit
-193.51M
ROE
-68.55%
ROA
-51.03%

Ocular Therapeutix Inc Earnings Date

Latest Release
Aug 3, 2026
EPS / Forecast
-0.35/-0.40
Revenue / Forecast
13.47M/13.20M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
10.89%-0.35
-4.57%-0.40
-0.76%-0.29
-72.72%-0.38
-48.83%-0.39
23.02%-0.38
12.93%-0.29
-3262.00%-0.22
0.37%-0.26
-25.38%-0.49
-63.82%-0.33
---0.01
---0.26
---0.39
---0.20
---0.72
----
----
----
----
Revenue
0.12%13.47M
0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
15.41%17.08M
2.28%15.43M
8.26%16.44M
10.47%14.77M
5.16%14.80M
26.04%15.08M
23.81%15.19M
1.42%13.37M
14.36%14.07M
-1.55%11.96M
4.68%12.27M
79.61%13.19M
67.48%12.31M
106.82%12.15M
Net Profit
-16.15%-78.76M
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
95.50%-3.85M
122.25%2.66M
Net Margin
-16.01%-584.51%
-37.23%-821.62%
-72.26%-487.95%
-101.75%-477.30%
-89.23%-503.86%
-36.41%-598.74%
-43.49%-283.27%
-6814.57%-236.58%
-95.51%-266.27%
-93.62%-438.93%
-78.78%-197.42%
---3.42%
---136.19%
---226.69%
---110.42%
---148.31%
----
----
----
----
Gross Margin
-0.56%85.08%
-0.60%87.68%
-5.20%87.97%
-2.31%87.80%
-5.80%85.56%
-3.10%88.20%
2.39%92.80%
-1.09%89.88%
-0.65%90.82%
0.11%91.02%
-2.34%90.64%
--90.87%
--91.41%
--90.92%
--92.81%
--90.57%
----
----
----
----
Debt to assets ratio
-29.99%10.84%
-42.30%9.84%
-40.99%8.83%
24.28%17.19%
19.30%15.49%
38.26%17.05%
-49.67%14.96%
-69.61%13.83%
-71.26%12.98%
-71.01%12.33%
-17.83%29.73%
--45.50%
--45.18%
--42.53%
--36.18%
--33.64%
----
----
----
----
Income Statement
Revenue
0.12%13.47M
0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
15.41%17.08M
2.28%15.43M
8.26%16.44M
10.47%14.77M
5.16%14.80M
26.04%15.08M
23.81%15.19M
1.42%13.37M
14.36%14.07M
-1.55%11.96M
4.68%12.27M
79.61%13.19M
67.48%12.31M
106.82%12.15M
Operating profit
-21.39%-82.11M
-46.03%-93.34M
-37.93%-69.76M
-49.35%-68.70M
-55.18%-67.64M
-102.16%-63.92M
-152.25%-50.58M
-139.40%-46.00M
-111.91%-43.59M
-40.21%-31.62M
-3.56%-20.05M
10.82%-19.21M
-3.28%-20.57M
-26.45%-22.55M
-7.27%-19.36M
-10.32%-21.54M
1.56%-19.92M
11.84%-17.83M
-25.84%-18.05M
-39.43%-19.53M
Net Profit
-16.15%-78.76M
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
95.50%-3.85M
122.25%2.66M
Balance Sheet
Current assets
48.70%644.43M
82.10%706.00M
77.36%782.13M
-18.19%386.98M
-13.08%433.38M
-25.42%387.69M
89.89%440.99M
234.86%473.01M
395.06%498.58M
385.08%519.82M
79.16%232.24M
-2.99%141.26M
-37.18%100.71M
-38.64%107.16M
-32.24%129.63M
-28.60%145.62M
-25.96%160.32M
-23.44%174.65M
-22.29%191.30M
148.99%203.93M
Total current liabilities
14.54%49.17M
25.73%47.68M
22.86%50.81M
35.58%49.29M
43.24%42.93M
56.09%37.93M
18.51%41.35M
3.69%36.36M
-7.37%29.97M
-18.23%24.30M
11.15%34.90M
19.81%35.07M
23.91%32.36M
24.02%29.71M
19.20%31.39M
16.34%29.27M
21.17%26.11M
-12.67%23.96M
-1.23%26.34M
9.83%25.16M
Total assets
48.74%671.32M
80.46%732.53M
76.46%808.06M
-16.21%410.88M
-12.72%451.33M
-24.68%405.92M
81.68%457.94M
201.98%490.37M
321.92%517.09M
319.18%538.95M
68.84%252.06M
2.40%162.38M
-29.19%122.56M
-31.47%128.57M
-27.14%149.29M
-27.17%158.58M
-24.98%173.07M
-22.80%187.62M
-21.76%204.89M
121.69%217.74M
Total liabilities
4.03%151.28M
7.83%150.96M
7.82%153.75M
10.34%152.65M
4.32%145.42M
6.89%139.99M
-11.40%142.59M
-10.47%138.35M
16.68%139.40M
10.18%130.96M
41.28%160.93M
37.54%154.53M
11.38%119.47M
10.23%118.86M
-2.55%113.91M
-13.84%112.35M
-28.71%107.27M
-32.45%107.83M
-37.08%116.89M
27.41%130.40M
Total equity
69.99%520.04M
118.69%581.57M
107.49%654.31M
-26.64%258.23M
-19.00%305.92M
-34.82%265.93M
246.03%315.34M
4382.63%352.02M
12135.02%377.69M
4101.25%407.98M
157.59%91.13M
-83.01%7.85M
-95.31%3.09M
-87.83%9.71M
-59.80%35.38M
-47.07%46.23M
-18.00%65.80M
-4.33%79.80M
15.64%88.00M
2216.82%87.34M
Cash Flow Statement
Net operating income
-21.79%-67.27M
-47.73%-65.99M
-37.59%-54.25M
-38.75%-50.73M
-122.72%-55.24M
-31.82%-44.67M
-75.60%-39.43M
-372.83%-36.56M
-23.55%-24.80M
-69.66%-33.89M
-32.41%-22.45M
41.29%-7.73M
-84.58%-20.07M
-7.38%-19.97M
-11.91%-16.96M
-1.44%-13.17M
45.77%-10.88M
-7.15%-18.60M
-142.64%-15.15M
4.95%-12.98M
Net investment
-201.97%-3.37M
-141.18%-4.66M
-1305.45%-2.84M
-6633.71%-5.99M
-50.27%-1.11M
-658.04%-1.93M
55.99%-202.00K
65.64%-89.00K
62.71%-742.00K
92.45%-255.00K
78.65%-459.00K
67.38%-259.00K
-302.02%-1.99M
-1124.28%-3.38M
-240.73%-2.15M
-187.68%-794.00K
-283.72%-495.00K
-74.68%-276.00K
-149.41%-631.00K
-28.97%-276.00K
Net financing
-97.36%2.58M
-92.97%294.00K
9857.37%449.38M
147.87%10.36M
4353.83%97.81M
-98.70%4.18M
-95.83%4.51M
-91.96%4.18M
-77.23%2.20M
411724.36%321.22M
23517.90%108.17M
13786.36%51.94M
1856.39%9.64M
-39.53%78.00K
-31.33%458.00K
-44.92%374.00K
-81.51%493.00K
111.10%129.00K
-99.59%667.00K
208.64%679.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its total revenue reached 51.95M, with a year-on-year change of 63.72M.

What are the current assets of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its current assets were 782.13M, with a year-on-year change of 77.36.

What are the total assets of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its total assets of Ocular Therapeutix Inc were 808.06M, with a year-on-year change of 76.46.

What are the total liabilities of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its total liabilities of Ocular Therapeutix Inc were 153.75M, with a year-on-year change of 7.82.

What is the total equity of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its total equity of Ocular Therapeutix Inc was 654.31M, with a year-on-year change of 107.49.

What is the net operating income of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its net operating income of Ocular Therapeutix Inc was -270.02M, with a year-on-year change of -57.19.

What is the net investment of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its net investment of Ocular Therapeutix Inc was -11.88M, with a year-on-year change of -822.36.

What is the net financing of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its net financing of Ocular Therapeutix Inc was 561.72M, with a year-on-year change of 69.14.

What is the Earnings Per Share (EPS) of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.42, with a year-on-year change of -16.16.

What is the net income of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its net income was -265.94M, with a year-on-year change of -37.43.

What is the net margin of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its net profit margin was -511.90, with a year-on-year change of -68.57.

What is the gross margin of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its gross margin was 87.35, with a year-on-year change of -4.20.

What is the debt-to-asset ratio of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its debt-to-asset ratio was 8.83, with a year-on-year change of -40.99.

What is the Return on Equity (ROE) of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its Return on Equity (ROE) was -54.85, with a year-on-year change of 42.39.

What is the Return on Assets (ROA) of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.01, with a year-on-year change of 22.93.

What is the operating profit of Ocular Therapeutix Inc?

According to Ocular Therapeutix Inc's FY2025 earnings report, its operating profit was -270.02M, with a year-on-year change of -57.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy